International Journal of Clinical Oncology

, Volume 22, Issue 4, pp 740–748 | Cite as

Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection

  • Ryuma Tokunaga
  • Yasuo Sakamoto
  • Shigeki Nakagawa
  • Daisuke Izumi
  • Keisuke Kosumi
  • Katsunobu Taki
  • Takaaki Higashi
  • Tatsunori Miyata
  • Yuji Miyamoto
  • Naoya Yoshida
  • Hideo Baba
Original Article

Abstract

Background

Various systemic inflammatory and nutritional scores have been reported to predict postoperative outcomes. This study aimed to investigate the best systemic inflammatory and nutritional scores in colorectal cancer (CRC) patients who underwent potentially curative resection.

Method

We evaluated 468 consecutive CRC patients in this study. Comparisons of systemic inflammatory and nutritional scores, including the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), prognostic index (PI), prognostic nutritional index (PNI), and modified Glasgow prognostic score (mGPS), were performed using univariate/multivariate analyses for patient survival.

Results

The PNI and mGPS, but not the NLR, PLR, and PI, were significantly associated with overall and relapse-free survival. The mGPS, but not the PNI, was strongly correlated with TNM stage (P < 0.001). Cox multivariate analysis showed that both the PNI and mGPS were exclusive independent prognostic factors for both overall and relapse-free survival (P < 0.001). Furthermore, the PNI status predicted patient survival more clearly than the mGPS in combination with TNM stage.

Conclusions

This study suggests that the PNI and mGPS are useful predictive scores in CRC patients who undergo potentially curative resection, especially the PNI in combination with TNM stage. Routine evaluation of the host status using the scores may be useful in CRC treatment.

Keywords

Colorectal cancer Modified Glasgow prognostic score Prognostic nutritional index Systemic inflammatory and nutritional scores Treatment 

Abbreviations

CRC

Colorectal cancer

mGPS

Modified Glasgow prognostic score

CRP

C-reactive protein

NLR

Neutrophil to lymphocyte ratio

PLR

Platelet to lymphocyte ratio

PI

Prognostic index

PNI

Prognostic nutritional index

BMI

Body mass index

CEA

Carcinoembryonic antigen

HR

Hazard ratio

CI

Confidence interval

OS

Overall survival

DFS

Disease-free survival

Supplementary material

10147_2017_1102_MOESM1_ESM.docx (19 kb)
Supplementary material 1 (DOCX 18 kb)
10147_2017_1102_MOESM2_ESM.docx (29 kb)
Supplementary material 2 (DOCX 29 kb)

References

  1. 1.
    Oshima H, Nakayama M, Han TS et al (2015) Suppressing TGFbeta signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer. Cancer Res 75:766–776CrossRefPubMedGoogle Scholar
  2. 2.
    Bozzetti F (2002) Rationale and indications for preoperative feeding of malnourished surgical cancer patients. Nutrition 18:953–959CrossRefPubMedGoogle Scholar
  3. 3.
    Meguid MM, Mughal MM, Debonis D et al (1986) Influence of nutritional status on the resumption of adequate food intake in patients recovering from colorectal cancer operations. Surg Clin North Am 66:1167–1176CrossRefPubMedGoogle Scholar
  4. 4.
    Onodera T, Goseki N, Kosaki G (2014) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 10:1–7Google Scholar
  5. 5.
    Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85:1001–1005PubMedGoogle Scholar
  6. 6.
    Gomes de Lima KV, Maio R (2012) Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp 27:707–714PubMedGoogle Scholar
  7. 7.
    Park JH, Watt DG, Roxburgh CS et al. (2015) colorectal cancer, systemic inflammation, and outcome: staging the tumor and staging the host. Ann Surg. 236(2): 326−36Google Scholar
  8. 8.
    The Japanese society for cancer of the colon and rectum (2005) JSCCR guidelines 2005 for the treatment of colorectal cancer. Kanehara and Co., Ltd, TokyoGoogle Scholar
  9. 9.
    The Japanese society for cancer of the colon and rectum (2010) JSCCR Guidelines 2010 for the treatment of colorectal cancer. Kanehara and Co., Ltd, TokyoGoogle Scholar
  10. 10.
    Watanabe T, Itabashi M, Shimada Y et al (2012) Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 17:1–29CrossRefPubMedGoogle Scholar
  11. 11.
    Sobin LHGMWC (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, New YorkGoogle Scholar
  12. 12.
    Mallappa S, Sinha A, Gupta S et al (2013) Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 15:323–328CrossRefPubMedGoogle Scholar
  13. 13.
    Smith RA, Bosonnet L, Raraty M et al (2009) Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg 197:466–472CrossRefPubMedGoogle Scholar
  14. 14.
    Proctor MJ, Morrison DS, Talwar D et al (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 47:2633–2641CrossRefPubMedGoogle Scholar
  15. 15.
    Mohri Y, Inoue Y, Tanaka K et al (2013) Prognostic nutritional index predicts postoperative outcome in colorectal cancer. World J Surg 37:2688–2692CrossRefPubMedGoogle Scholar
  16. 16.
    Tarantino I, Warschkow R, Worni M et al (2012) Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer 107:266–274CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Stiksma J, Grootendorst DC, van der Linden PW (2014) CA 19-9 as a marker in addition to CEA to monitor colorectal cancer. Clin Colorectal Cancer 13:239–244CrossRefPubMedGoogle Scholar
  18. 18.
    Mantovani A, Allavena P, Sica A et al (2008) Cancer-related inflammation. Nature 454:436–444CrossRefPubMedGoogle Scholar
  19. 19.
    Heys SD, Walker LG, Deehan DJ et al (1998) Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43:163–168PubMedGoogle Scholar
  20. 20.
    Kinoshita A, Onoda H, Imai N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Guthrie GJ, Roxburgh CS, Farhan-Alanie OM et al (2013) Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer 109:24–28CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Cedres S, Torrejon D, Martinez A et al (2012) Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol 14:864–869CrossRefPubMedGoogle Scholar
  23. 23.
    Jin H, Zhang G, Liu X et al (2013) Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol 11:112CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lee S, Oh SY, Kim SH et al (2013) Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer 13:350CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Yao Y, Yuan D, Liu H et al (2013) Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy. Cancer Immunol Immunother 62:471–479CrossRefPubMedGoogle Scholar
  26. 26.
    Tokunaga R, Sakamoto Y, Nakagawa S et al (2015) Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection. Dis Colon Rectum 58:1048–1057CrossRefPubMedGoogle Scholar
  27. 27.
    Dutta S, Crumley AB, Fullarton GM et al (2012) Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Am J Surg 204:294–299CrossRefPubMedGoogle Scholar
  28. 28.
    Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663–2668CrossRefPubMedGoogle Scholar
  29. 29.
    Moon HG, Ju YT, Jeong CY et al (2008) Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 15:1918–1922CrossRefPubMedGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2017

Authors and Affiliations

  • Ryuma Tokunaga
    • 1
  • Yasuo Sakamoto
    • 1
  • Shigeki Nakagawa
    • 1
  • Daisuke Izumi
    • 1
  • Keisuke Kosumi
    • 1
  • Katsunobu Taki
    • 1
  • Takaaki Higashi
    • 1
  • Tatsunori Miyata
    • 1
  • Yuji Miyamoto
    • 1
  • Naoya Yoshida
    • 1
  • Hideo Baba
    • 1
  1. 1.Department of Gastroenterological Surgery, Graduate School of Medical SciencesKumamoto UniversityKumamotoJapan

Personalised recommendations